Tushar Shah
Directeur Technique/Scientifique/R&D chez Liquidia Technologies, Inc.
Profil
Tushar Shah is currently the Chief Medical Officer at Liquidia Technologies, Inc. He previously held positions as Head-Global Specialty Clinical Development at Teva Pharmaceutical Industries Ltd., Head-US Respiratory & Inflammation at GSK Plc, and Senior VP-Scientific & Clinical Development at ALTANA Pharma US, Inc. He also served as the Chief Medical Officer at Liquidia Corp.
from 2020 to 2022.
Shah holds a doctorate degree from The Pennsylvania State University and Pennsylvania State University College of Medicine.
Postes actifs de Tushar Shah
| Sociétés | Poste | Début |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Directeur Technique/Scientifique/R&D | 18/05/2020 |
Anciens postes connus de Tushar Shah
| Sociétés | Poste | Fin |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur Technique/Scientifique/R&D | 15/06/2022 |
| GSK PLC | Corporate Officer/Principal | - |
ALTANA Pharma US, Inc.
 ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Directeur Technique/Scientifique/R&D | - |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Formation de Tushar Shah
| The Pennsylvania State University | Doctorate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Health Technology |